Concepedia

Desislava Ignatova

DI

Statistics

Publications

16

Citations

686

H-Index

13

Active since

2015

Affiliations

University Hospital of Zurich(Current)

University of Zurich

Kepler Universitätsklinikum

University of Lausanne

Kantonsspital St. Gallen

Desislava Ignatova is an author at University Hospital of Zurich specializing in oncology, immunology, and cancer immunology.

Publications per year

2015–2024

16

Publications

16

IL-4 abrogates T <sub>H</sub> 17 cell-mediated inflammation by selective silencing of IL-23 in antigen-presenting cells

Emmanuella Guenova, Yuliya Skabytska, Wolfram Hoetzenecker et al. · Proceedings of the National Academy of Sciences · 2015 · 181 citations · Full text

Life Sciences, Immunology, Pathology +17

Oncolytic virotherapy-mediated anti-tumor response: a single-cell perspective

Egle Ramelyte, Aizhan Tastanova, Zsolt Balázs et al. · Cancer Cell · 2021 · 108 citations · Full text

Medicine, Cancer Biology, Oncology +14

A novel proangiogenic B cell subset is increased in cancer and chronic inflammation

Willem van de Veen, Anna Głobińska, Kirstin Jansen et al. · Science Advances · 2020 · 71 citations · Full text

Medicine, Immunology, Oncology +16

Blockade of programmed cell death protein 1 (PD-1) in Sézary syndrome reduces Th2 phenotype of non-tumoral T lymphocytes but may enhance tumor proliferation

Ieva Saulīte, Desislava Ignatova, Yun‐Tsan Chang et al. · OncoImmunology · 2020 · 62 citations · Full text

Life Sciences, Immunology, Oncology +17

PD-L1 expression is an independent predictor of favorable outcome in patients with localized esophageal adenocarcinoma

Dagmar Kollmann, Desislava Ignatova, Julia Jedamzik et al. · OncoImmunology · 2018 · 40 citations · Full text

Life Sciences, Immunology, Oncology +17

1–5 of 16